Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study.

Jianhua WuRamesh Nadarajah Yoko M Nakao Kazuhiro NakaoDavid HoggKeerthenan RaveendraRonen ArbelMoti HaimDoron ZahgerCampbel CowanChris P Gale

Published in: Open heart (2023)

Individuals identified for risk-guided AF screening are at risk of new diseases across the cardio-renal-metabolic spectrum and death, and may benefit from interventions beyond ECG monitoring.

Keyphrases

atrial fibrillation
cardiovascular disease
heart failure
physical activity
left atrial appendage
left atrial
type diabetes
heart rate
blood pressure
catheter ablation
heart rate variability
oral anticoagulants
direct oral anticoagulants
coronary artery disease
acute coronary syndrome
venous thromboembolism